Back

Cohort profile: the SEROCoV-KIDS population-based cohort study and biobank on the impact of the COVID-19 pandemic in children and adolescents in Geneva, Switzerland

Lorthe, E.; Loizeau, A.; Richard, V.; Dumont, R.; Zaballa, M.-E.; Pennacchio, F.; Lamour, J.; L'huillier, A. G.; Baysson, H.; Fernandez Clares, N.; Bovio, N.; Nehme, M.; Lescuyer, P.; Vuilleumier, N.; Posfay-Barbe, K. M.; Barbe, R. P.; SEROCoV-KIDS Study group, ; Guessous, I.; Stringhini, S.

2026-01-16 epidemiology
10.64898/2026.01.14.26344108 medRxiv
Show abstract

PurposeThe COVID-19 pandemic has had profound and multifaceted impacts on children and adolescents, exposing and deepening pre-existing inequalities while creating unique health, social, and educational challenges. In response to the limited evidence-based knowledge available, the SEROCoV-KIDS study was launched in 2021 as a prospective cohort and biobank to assess the pandemics effects on youth health and well-being. It focuses on the general population of Geneva, Switzerland, as well as subgroups with vulnerabilities, including prior SARS-CoV-2 infection, chronic health conditions, and socioeconomic disadvantage. ParticipantsA total of 2199 children and adolescents, aged 6 months to 17 years, from 1340 households were enrolled in the SEROCoV-KIDS cohort, 2048 from the general population and 151 from clinics (i.e., children with chronic health conditions). At baseline, between December 2021 and June 2022, participants provided blood samples for serological testing and for long-term storage in the biobank, while comprehensive questionnaires were completed by a referent adult and adolescents aged 14 and older. Five follow-up online assessments were conducted until October 2025, addressing physical and mental health, development, quality of life, health behaviors, family dynamics, and education-related topics. The quantitative findings of the cohort study were enriched by a cross-sectional qualitative study conducted between October 2023 and March 2024, focusing specifically on socioeconomically disadvantaged populations. Findings to dateIn the population-based sample, 66.3% of participants tested seropositive for anti-SARS-CoV-2 nucleocapsid antibodies at baseline, and 4.1% reported symptoms consistent with post-COVID condition. Most children were minimally or not at all affected by the pandemic, showing good mental health over time. However, 8% of participants reported a positive pandemic impact, whereas 8-13% experienced negative impacts, mainly due to disrupted routines and reduced social support. Health behaviors like physical activity and sleep remained largely stable over the study period. Higher screen time at baseline was associated with poorer well-being. Children with chronic health conditions or experiencing socioeconomic and family disadvantage were disproportionately affected in terms of the health and psychosocial consequences of the pandemic. Future plansSEROCoV-KIDS demonstrates the value of child-focused cohorts for understanding the consequences of major societal events and for guiding evidence-based policy. Our next priority is to secure funding to prolong follow-up of this cohort and to maintain systematic surveillance of children and adolescents, so that emerging findings can directly inform public health and education policy over the coming years. Strengths and limitations of this studyO_LIThis large population-based pediatric cohort provides insights into the health and well-being of children and adolescents aged 6 months to 17 years at baseline, during and after the COVID-19 pandemic (from December 2021 to October 2025). C_LIO_LIThis study integrates multifaceted findings on the general pediatric population and on subgroups of children with clinical and/or social vulnerabilities, combining quantitative and qualitative data to provide a deeper understanding of how the pandemic has affected their lives. C_LIO_LIThis unique pediatric cohort and its associated biobank offer a rare opportunity to advance future pediatric research in Switzerland and abroad. C_LIO_LIGeneralizability may be limited, as participating families tended to be more highly educated and somewhat more socioeconomically advantaged than the general Geneva population, despite nearly one-fifth reporting financial difficulties. C_LIO_LIThe study was designed in response to the pandemic, and individual-level pre-pandemic data are lacking, which limits direct comparisons over time, relying instead on parent-reported perception of changes and impacts. C_LI

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
BMJ Open
554 papers in training set
Top 0.1%
41.9%
2
International Journal of Epidemiology
74 papers in training set
Top 0.2%
7.2%
3
International Journal of Public Health
17 papers in training set
Top 0.1%
5.2%
50% of probability mass above
4
Frontiers in Public Health
140 papers in training set
Top 2%
3.3%
5
PLOS ONE
4510 papers in training set
Top 45%
2.5%
6
International Journal of Environmental Research and Public Health
124 papers in training set
Top 3%
2.2%
7
Scientific Reports
3102 papers in training set
Top 48%
2.2%
8
European Child & Adolescent Psychiatry
14 papers in training set
Top 0.2%
2.0%
9
Swiss Medical Weekly
12 papers in training set
Top 0.1%
2.0%
10
BMJ Paediatrics Open
21 papers in training set
Top 0.4%
1.8%
11
European Journal of Public Health
20 papers in training set
Top 0.5%
1.6%
12
Nature Human Behaviour
85 papers in training set
Top 3%
1.4%
13
Journal of Epidemiology and Community Health
32 papers in training set
Top 0.4%
1.4%
14
BMC Public Health
147 papers in training set
Top 4%
1.3%
15
Developmental Cognitive Neuroscience
81 papers in training set
Top 0.4%
0.9%
16
BMJ
49 papers in training set
Top 0.9%
0.9%
17
Social Psychiatry and Psychiatric Epidemiology
11 papers in training set
Top 0.4%
0.9%
18
eClinicalMedicine
55 papers in training set
Top 1%
0.8%
19
Frontiers in Psychiatry
83 papers in training set
Top 3%
0.8%
20
European Respiratory Journal
54 papers in training set
Top 2%
0.8%
21
PLOS Digital Health
91 papers in training set
Top 3%
0.7%
22
European Journal of Epidemiology
40 papers in training set
Top 0.8%
0.7%
23
Journal of Psychiatric Research
28 papers in training set
Top 0.9%
0.7%
24
The Lancet Regional Health - Europe
32 papers in training set
Top 0.5%
0.7%
25
The Lancet Regional Health - Americas
22 papers in training set
Top 0.5%
0.5%
26
Nature Communications
4913 papers in training set
Top 66%
0.5%
27
PLOS Medicine
98 papers in training set
Top 5%
0.5%